2023-08-07 12:46:32 ET
- Syros Pharmaceuticals ( NASDAQ: SYRS ) is scheduled to announce Q2 earnings results on Tuesday, August 8th, before market open.
- The consensus EPS Estimate is -$1.13 and the consensus Revenue Estimate is $3.5M (-44.3% Y/Y).
- Over the last 2 years, SYRS has beaten EPS estimates 38% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 1 downward.
For further details see:
Syros Pharmaceuticals Q2 2023 Earnings Preview